These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4816)

  • 21. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
    Singer G; Armstrong S; Evans B; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of peripherally administered 6-hydroxydopamine on food and water intake in rats.
    Gardiner SM; Bennett T
    Med Biol; 1978 Jun; 56(3):156-60. PubMed ID: 682699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride.
    Wagner GC; Foltin RW; Seiden LS; Schuster CR
    Pharmacol Biochem Behav; 1981 Jan; 14(1):85-8. PubMed ID: 7465611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Learning impairments after 6-OHDA treatment: a comparison with the effects of thiamine deficiency.
    Anderson CD; Mair RG; Langlais PJ; McEntee WJ
    Behav Brain Res; 1986 Jul; 21(1):21-7. PubMed ID: 3091046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of selective lesioning of brain catecholamine-containing neurons on the activity of various anorectics in thr rat.
    Samanin R; Bernasconi S; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):373-5. PubMed ID: 1234557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):887-93. PubMed ID: 1208631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats.
    Phillips AG; Fibiger HC
    Behav Biol; 1976 Feb; 16(2):127-43. PubMed ID: 1259675
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin acts through catecholaminergic mechanisms in the hypothalamus to influence ingestive behaviour in the rat.
    Tsai SH; Passaro E; Lin MT
    Neuropharmacology; 1984 Nov; 23(11):1351-6. PubMed ID: 6441894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of 6-hydroxydopamine on the antinociceptive action of morphine.
    Slater P; Blundell C
    Eur J Pharmacol; 1978 Apr; 48(3):237-47. PubMed ID: 639852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats.
    Zigmond MJ; Stricker EM
    Science; 1972 Sep; 177(4055):1211-4. PubMed ID: 5057630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 6-hydroxydopamine, dopamine and dl-norepinephrine on food intake and water consumption, self-stimulation, temperature and electroencephalographic activity in the rat.
    Hansen MG; Whishaw IQ
    Psychopharmacologia; 1973 Feb; 29(1):33-44. PubMed ID: 4695205
    [No Abstract]   [Full Text] [Related]  

  • 36. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of dorsal bundle injections of 6-hydroxydopamine on avoidance responding in rats.
    Fibiger HC; Mason ST
    Br J Pharmacol; 1978 Dec; 64(4):601-5. PubMed ID: 728687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 40. Catecholamine-serotonin interaction effects on activity in rats neonatally treated with 6-hydroxydopamine.
    Olds ME; Fobes JL; Albert V
    Psychopharmacology (Berl); 1981; 73(1):31-3. PubMed ID: 6785786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.